0.26
+0.0019(+0.75%)
Currency In USD
Address
10355 Science Center Drive
San Diego, CA 92121
United States of America
Phone
212 582 1199
Website
Sector
Healthcare
Industry
Biotechnology
Employees
8
First IPO Date
August 29, 1991
| Name | Title | Pay | Year Born |
| Mr. Sanjeev Luther | Chief Executive Officer, President & Director | 0 | 1962 |
| Ms. Sandra M. Gurrola | Principal Financial & Accounting Officer and Senior Vice President of Finance | 305,883 | 1967 |
| Ms. Dorothy J. Clarke | General Counsel | 0 | 1966 |
| Dr. Robert Hamilton Pierce M.D. | Chief Scientific Officer | 0 | 1964 |
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.